IL6 and COVID-19: Additional evidence of the relevance of IL-6 and their receptors in COVID-19 is the reporting of successful therapeutical use of monoclonal antibodies anti-IL-6 receptors in COVID-19, whose use has been proven to be effective in a number of autoimmune diseases [3,4].